NCT01143038 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 75
- units
- Participants
- groups
- description
- Participants received romiplostim administered weekly by subcutaneous injection during the 12-month treatment period. The starting dose was 1 μg/kg with weekly dose increases in increments of 1 μg/kg/week to a maximum dose of 10 μg/kg to reach a target platelet count of ≥ 50 x 10\^9/L. At the completion of the 12-month treatment period, participants receiving only romiplostim and with a platelet count ≥ 50 x 10\^9/L entered the tapering period, during which the romiplostim dose was decreased by 1 µg/kg every 2 weeks, for up to 19 weeks. Participants who had tapered off treatment with romiplostim and whose platelet count dropped below 50 x 10\^9/L could reinitiate romiplostim for up to 8 weeks.
- id
- BG000
- title
- Romiplostim
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 18.7
- value
- 44.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 44
- title
- Female
- measurements
- group Id
- BG000
- value
- 31
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Black (or African American)
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 72
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- param Type
- NUMBER
- title
- Race
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 69
- title
- Not Hispanic/Latino
- param Type
- NUMBER
- title
- Ethnicity
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0.1
- upper Limit
- 6.6
- value
- 2.2
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Time since ITP diagnosis
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.80
- value
- 19.78
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Platelet Count at Screening
- unit Of Measure
- x 10^9/L
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 75
- units
- Participants
- groups
- description
- Participants received romiplostim administered weekly by subcutaneous injection during the 12-month treatment period. The starting dose was 1 μg/kg with weekly dose increases in increments of 1 μg/kg/week to a maximum dose of 10 μg/kg to reach a target platelet count of ≥ 50 x 10\^9/L. At the completion of the 12-month treatment period, participants receiving only romiplostim and with a platelet count ≥ 50 x 10\^9/L entered the tapering period, during which the romiplostim dose was decreased by 1 µg/kg every 2 weeks, for up to 19 weeks. Participants who had tapered off treatment with romiplostim and whose platelet count dropped below 50 x 10\^9/L could reinitiate romiplostim for up to 8 weeks.
- id
- BG000
- title
- Romiplostim
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 18.7
- value
- 44.5
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 44
- title
- Female
- measurements
- group Id
- BG000
- value
- 31
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Black (or African American)
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- categories
- measurements
- group Id
- BG000
- value
- 72
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- param Type
- NUMBER
- title
- Race
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 6
- title
- Hispanic/Latino
- categories
- measurements
- group Id
- BG000
- value
- 69
- title
- Not Hispanic/Latino
- param Type
- NUMBER
- title
- Ethnicity
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0.1
- upper Limit
- 6.6
- value
- 2.2
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Time since ITP diagnosis
- unit Of Measure
- months
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.80
- value
- 19.78
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Platelet Count at Screening
- unit Of Measure
- x 10^9/L
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle